116 related articles for article (PubMed ID: 2294062)
21. Structural study of the sugar chains of alpha-amylases produced ectopically in tumors.
Yamashita K; Tachibana Y; Takeuchi T; Kobata A
J Biochem; 1981 Nov; 90(5):1281-9. PubMed ID: 6175619
[TBL] [Abstract][Full Text] [Related]
22. Amylase-containing ovarian cystadenocarcinoma simulating a pancreatic pseudocyst.
Joseph RR; Frey CF; Michaels R; McCann DS
Am J Obstet Gynecol; 1976 Oct; 126(4):515-6. PubMed ID: 984118
[No Abstract] [Full Text] [Related]
23. Amylase activity and fast-migrating amylase isoenzymes in serum and cyst fluid from patients with ovarian neoplasms.
Henriksen R; Brock A
Acta Obstet Gynecol Scand; 1988; 67(1):65-70. PubMed ID: 2459898
[TBL] [Abstract][Full Text] [Related]
24. Coexpression of cytokeratins and vimentin in common epithelial tumours of the ovary: an immunocytochemical study of eighty-three cases.
Viale G; Gambacorta M; Dell'Orto P; Coggi G
Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):91-101. PubMed ID: 2455381
[TBL] [Abstract][Full Text] [Related]
25. Ovarian mucinous cystadenoma of borderline malignancy in a premenarchal girl.
Iwasaki M; Taira K; Kobayashi H; Saiga T
J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):e119-23. PubMed ID: 19896401
[TBL] [Abstract][Full Text] [Related]
26. Expression of c-myc and mutation of the KRAS gene in patients with ovarian mucinous tumors.
Li XS; Sun J; He XL
Genet Mol Res; 2015 Sep; 14(3):10752-9. PubMed ID: 26400304
[TBL] [Abstract][Full Text] [Related]
27. Serum CA19.9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype.
Kelly PJ; Archbold P; Price JH; Cardwell C; McCluggage WG
J Clin Pathol; 2010 Feb; 63(2):169-73. PubMed ID: 20154039
[TBL] [Abstract][Full Text] [Related]
28. Amylase-producing ovarian neoplasm with pseudo-Meigs' syndrome and elevated pleural fluid amylase: case report and ultrastructure.
Cramer SF; Bruns DE
Cancer; 1979 Nov; 44(5):1715-21. PubMed ID: 498043
[TBL] [Abstract][Full Text] [Related]
29. Carcinoembryonic antigen in ovarian epithelial cystadenocarcinomas: the prognostic value of tumor and serial plasma determinations.
van Nagell JR; Donaldson ES; Gay EC; Sharkey RM; Rayburn P; Goldenberg DM
Cancer; 1978 Jun; 41(6):2335-40. PubMed ID: 350376
[No Abstract] [Full Text] [Related]
30. [Relationship between malignant transformation of ovarian mucinous cystadenoma and intestinal epithelial metaplasia].
Zhong CQ
Zhonghua Bing Li Xue Za Zhi; 1989 Jun; 18(2):134-6. PubMed ID: 2555075
[TBL] [Abstract][Full Text] [Related]
31. Comparison of biochemical markers between benign and malignant ovarian cysts.
Knight JA; Wu JT; Miya T; Knight DP
Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
[TBL] [Abstract][Full Text] [Related]
32. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
[TBL] [Abstract][Full Text] [Related]
33. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia].
Nakamura S; Hirabayashi N; Asai J
Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
[TBL] [Abstract][Full Text] [Related]
35. [Clinical and pathological studies on amylase-producing ovarian cancer].
Matsuda M; Izutsu T; Kagabu T; Nishiya I; Iida H; Kubota T
Nihon Gan Chiryo Gakkai Shi; 1985 Jun; 20(5):935-42. PubMed ID: 2414384
[No Abstract] [Full Text] [Related]
36. [Superficial epithelial-stromal ovarian tumors in girls].
Zuntová A; Teslík L; Smelhaus V
Cesk Patol; 1997 Feb; 33(1):9-20. PubMed ID: 9221220
[TBL] [Abstract][Full Text] [Related]
37. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
38. Management of ovarian carcinoma: a review of 14 years' experience at Beth Israel Hospital.
Blinick G; Kabakow B; Antopol W; Wallach RC
Mt Sinai J Med; 1972; 39(5):447-57. PubMed ID: 4628079
[No Abstract] [Full Text] [Related]
39. [Unique form of ovarian cancer with a stable increase in blood and urinary amylase activity].
Khazanov AI; Ivlev AS; Rybakova TG; Timofeev VA; Zhuravlev AP
Klin Med (Mosk); 1982 Feb; 60(2):93-5. PubMed ID: 6175790
[No Abstract] [Full Text] [Related]
40. Periodic acid-Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors.
Aalto ML; Collan Y
Int J Gynaecol Obstet; 1986 Feb; 24(1):27-34. PubMed ID: 2874066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
